FXR also stimulates the expression of silent information regulator sirtuin 1 (SIRT1), which inhibits fatty acid synthesis and promotes oxidation; loss of SIRT1 results in MASLD. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.